“Synergistic Potential of Linagliptin and Resveratrol in Mitigating Type-II Diabetes-Induced Nephropathy”: A Comprehensive Review
Open Access
- 6 March 2026
- journal article
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 22 (10) , 1-14
Abstract
This narrative review aims to elucidate the significance of the synergistic effects of linagliptin and resveratrol and also explores their individual mechanisms of action in diabetic complications such as nephropathy. A systematic literature analysis examined the synergistic potential of resveratrol and linagliptin in diabetic nephropathy. A critical review of their antioxidant, anti-inflammatory, and anti-fibrotic mechanisms was conducted. Various studies revealed that linagliptin improves renal outcomes through both incretin-dependent and independent pathways, reducing oxidative stress, inflammation, and AGE-RAGE axis activation. It also exhibits the capacity to reduce albuminuria and renal fibrosis in diabetic animal models. Resveratrol similarly demonstrates substantial renoprotective benefits through activation of the AMPK/Nrf2 pathway, mitigating oxidative stress and downregulating inflammatory markers such as tumor necrosis factor-alpha and interleukin-1 beta. The synergistic use of linagliptin and resveratrol may provide greater benefits than their individual effects, including improved glycaemic control, reduced renal oxidative stress, and decreased inflammatory and fibrotic markers, thereby offering superior protection against diabetic nephropathy.Keywords
This publication has 64 references indexed in Scilit:
- Effect of resveratrol on dipeptidyl peptidase-4 inhibitors pharmacokinetics: An in vitro and in vivo approachChemico-Biological Interactions, 2020
- Lycium chinense leaves extract ameliorates diabetic nephropathy by suppressing hyperglycemia mediated renal oxidative stress and inflammationBiomedicine & Pharmacotherapy, 2018
- Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathwayJournal of Molecular Medicine, 2016
- Renoprotective effect of DPP-4 inhibitors against free fatty acid-bound albumin-induced renal proximal tubular cell injuryBiochemical and Biophysical Research Communications, 2016
- DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese ratObesity, 2014
- Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetesBiochemical and Biophysical Research Communications, 2014
- Cerebroprotective effect of resveratrol through antioxidant and anti-inflammatory effects in diabetic ratsNaunyn-Schmiedeberg's Archives of Pharmacology, 2013
- Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK–SIRT1–PGC1α axis in db/db miceDiabetologia, 2012
- High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrolThe International Journal of Biochemistry & Cell Biology, 2012
- Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathyDiabetologia, 2001